TNF and ulcerative colitis: Because anti-TNF-α antibodies are associated with various adverse effects [14, 30], GWT may represent a potentially safer therapeutic agent for the various types of enterocolitis associated with CD or ulcerative colitis, both of which are well-known IBD.